Navidea Biopharmaceuticals Inc EPS Q/Q
What is the EPS Q/Q of Navidea Biopharmaceuticals Inc?
The EPS Q/Q of Navidea Biopharmaceuticals Inc is -38.46%
What is the definition of EPS Q/Q?
Quarterly EPS growth rate, year over year, is the increase of the company’s EPS for the most recent quarter compared to the the same quarter in the previous year.
quarterly growth yoy (year over year)
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with eps q/q similar to Navidea Biopharmaceuticals Inc
- Akzo Nobel NV has EPS Q/Q of -38.71%
- Aeglea BioTherapeutics Inc has EPS Q/Q of -38.71%
- InflaRx N.V has EPS Q/Q of -38.71%
- GE Aerospace has EPS Q/Q of -38.60%
- Semler Scientific has EPS Q/Q of -38.55%
- First Foundation Inc has EPS Q/Q of -38.55%
- Navidea Biopharmaceuticals Inc has EPS Q/Q of -38.46%
- J&J Snack Foods has EPS Q/Q of -38.41%
- Stemline Therapeutics has EPS Q/Q of -38.36%
- Black Diamond Therapeutics Inc has EPS Q/Q of -38.14%
- AngloGold Ashanti Plc has EPS Q/Q of -38.10%
- Franklin Resources has EPS Q/Q of -38.10%
- Allena Pharmaceuticals Inc has EPS Q/Q of -38.10%